AU Stock MarketDetailed Quotes

ACL Australian Clinical Labs Ltd

Watchlist
  • 2.280
  • -0.010-0.44%
20min DelayNot Open Jun 3 16:00 AET
460.18MMarket Cap12.74P/E (Static)

Australian Clinical Labs Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Total revenue
-30.04%692.1M
54.26%989.3M
641.31M
Operating revenue
-30.04%692.1M
54.26%989.3M
--641.31M
Cost of revenue
-39.26%126.08M
73.59%207.59M
119.59M
Gross profit
-27.59%566.02M
49.83%781.71M
521.73M
Operating expense
0.00%514.05M
23.41%514.03M
416.54M
Selling and administrative expenses
-5.29%297.39M
25.76%314M
--249.69M
-General and administrative expense
-5.29%297.39M
25.76%314M
--249.69M
Depreciation amortization depletion
15.70%122.76M
20.49%106.1M
--88.05M
-Depreciation and amortization
15.70%122.76M
20.49%106.1M
--88.05M
Other operating expenses
-0.03%93.9M
19.20%93.93M
--78.8M
Operating profit
-80.59%51.97M
154.47%267.68M
105.19M
Net non-operating interest income (expenses)
-16.91%-13.68M
46.54%-11.7M
-21.89M
Non-operating interest income
304.44%182K
-40.00%45K
--75K
Non-operating interest expense
164.38%3.54M
-87.76%1.34M
--10.94M
Total other finance cost
-0.82%10.33M
-5.62%10.41M
--11.03M
Other net income (expenses)
1,034.39%10.03M
-131.96%-1.07M
3.36M
Other non-operating income (expenses)
1,034.39%10.03M
-131.96%-1.07M
--3.36M
Income before tax
-81.05%48.31M
194.16%254.9M
86.65M
Income tax
-83.96%12.27M
191.27%76.5M
26.26M
Earnings from equity interest net of tax
Net income
-79.80%36.04M
195.42%178.4M
60.39M
Net income continuous operations
-79.80%36.04M
195.42%178.4M
--60.39M
Noncontrolling interests
-10.76%141K
887.50%158K
16K
Net income attributable to the company
-79.86%35.9M
195.24%178.24M
60.37M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-79.86%35.9M
195.24%178.24M
60.37M
Diluted earnings per share
-79.79%0.179
123.10%0.8855
0.3969
Basic earnings per share
-79.82%0.1785
122.88%0.8846
0.3969
Dividend per share
300.00%0.48
0.12
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021
Total revenue -30.04%692.1M54.26%989.3M641.31M
Operating revenue -30.04%692.1M54.26%989.3M--641.31M
Cost of revenue -39.26%126.08M73.59%207.59M119.59M
Gross profit -27.59%566.02M49.83%781.71M521.73M
Operating expense 0.00%514.05M23.41%514.03M416.54M
Selling and administrative expenses -5.29%297.39M25.76%314M--249.69M
-General and administrative expense -5.29%297.39M25.76%314M--249.69M
Depreciation amortization depletion 15.70%122.76M20.49%106.1M--88.05M
-Depreciation and amortization 15.70%122.76M20.49%106.1M--88.05M
Other operating expenses -0.03%93.9M19.20%93.93M--78.8M
Operating profit -80.59%51.97M154.47%267.68M105.19M
Net non-operating interest income (expenses) -16.91%-13.68M46.54%-11.7M-21.89M
Non-operating interest income 304.44%182K-40.00%45K--75K
Non-operating interest expense 164.38%3.54M-87.76%1.34M--10.94M
Total other finance cost -0.82%10.33M-5.62%10.41M--11.03M
Other net income (expenses) 1,034.39%10.03M-131.96%-1.07M3.36M
Other non-operating income (expenses) 1,034.39%10.03M-131.96%-1.07M--3.36M
Income before tax -81.05%48.31M194.16%254.9M86.65M
Income tax -83.96%12.27M191.27%76.5M26.26M
Earnings from equity interest net of tax
Net income -79.80%36.04M195.42%178.4M60.39M
Net income continuous operations -79.80%36.04M195.42%178.4M--60.39M
Noncontrolling interests -10.76%141K887.50%158K16K
Net income attributable to the company -79.86%35.9M195.24%178.24M60.37M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -79.86%35.9M195.24%178.24M60.37M
Diluted earnings per share -79.79%0.179123.10%0.88550.3969
Basic earnings per share -79.82%0.1785122.88%0.88460.3969
Dividend per share 300.00%0.480.12
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg